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Latino older adults were similar to Whites in odds of cognitive decline (OR
Latino 1.3; 95% CI 0.9-1.7). Conclusions: African American adults aged
65 and above were more likely to experience cognitive decline compared
to White older adults after accounting for demographics, socioeconomics,
comorbidity, and their baseline cognitive function. There was no difference
between Latino older adults and Whites in rates of cognitive decline.
Future research to identify ways to reduce cognitive decline, particularly
for racially-diverse groups, are needed.
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Background: Since our 1992 prevalence study there have been advances
in medications prescribed in the US for cardiovascular risk factors, while
at the same time there has been public health focus on healthful life styles.
Cardiovascular risk factors are now thought to confer risk for development
of Alzheimer’s disease, leading to speculation that rates Alzheimer’s dis-
ease (AD) may be declining. We compare prevalence rates for dementia
and Alzheimer’s disease in elderly African Americans in Indianapolis in
2001 and 1992. Methods: This is a 2001 prevalence study of a sample of
1893 African Americans age  70 years living independently in the
community. The study follows the same two stage design and methods as
were used in 1992. In Stage 1 all participants were given the in-home
Community Screening Interview for Dementia (CSI-D). CSI-D scores were
grouped into good performance, intermediate performance and poor per-
formance for sampling subjects for Stage 2, a full in- home clinical
assessment. Stage 2 includes the Consortium to Establish a Registry for
Alzheimer’s Disease (CERAD) neuropsychological test battery, standard-
ized physical, neurological, and functional assessment using the Clinician
Home-based Interview to Assess Function (CHIF), and the informant
interview based upon the Cambridge Examination for Mental Disorders in
the Elderly. Diagnoses were made in a consensus diagnostic conference
using standard criteria. We compare age specific prevalence rates for two
non overlapping cohorts assembled at two points in time. Results: The
overall age adjusted prevalence rate for dementia for the 2001 cohort was
7.38% (95% CI, 4.15-10.60) and for the 1992 cohort was 6.75% (95% CI,
5.77-7.74). The overall age adjusted prevalence rate for AD for the 2001
cohort was 6.77% (95% CI, 3.65-9.90) and for the 1992 cohort was 5.47%
(95% CI, 4.51-6.42). The rates for dementia and AD were not significantly
different for these two cohorts. Prevalence rates increased with age in both
cohorts. Conclusions: Although we have observed increases in prescrip-
tions for reducing cardiovascular risk factors in the nine years since our
first prevalence study we do not observe a declining rate in the prevalence
of dementia or AD in these elderly African American cohorts.
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Background: Both dementia and death increase rapidly with age in older
populations and so mortality competes with dementia. Projections of cu-
mulative incidence that do not take death into account (right censoring) do
not accurately reflect disease experience in an elderly cohort. Objective: In
groups at high risk for early mortality from diabetes or hypertension,
competing risk of death can result in an underestimate of the future lifetime
risk of dementia after age 60. This estimates the bias for gender, education
and nativity. Methods: The Sacramento Area Latino Study on Aging
(SALSA) is a cohort study of community dwelling older Mexican Amer-
icans aged 60-101 at baseline in 1998 of whom 50% were immigrants. This
cohort has been followed annually through early 2008 and characterized
for dementia incidence (DEM) and significant cognitive impairment
(CIND). Results: Type 2 diabetes baseline prevalence was 33%, metabolic
syndrome prevalence was 51% and 68% of the cohort had hypertension
(50% treated). To date, 25% (n451) of the cohort has died; age-adjusted
dementia/CIND incidence rates are 12 per 1,000 persons year in men and
14.1 per 1,000 person years in women. Mortality rates are 6.3/1,000 py in
men and 6.5/1,000 py in women. The purpose of this analysis is to use a
technique published by Beiser (2003) using Framingham data that adjusts
cumulative incidence rates for competing risk of death. The effects of this
adjustment on rates by gender, country of birth, and education are exam-
ined as lifetime risk of 20 years conditional on dementia-free survival to
age 60. Adjustment for competing risk of death substantially reduces the
projected 20-year lifetime risk for dementia/CIND (Table). The effects of
adjustment are greater in men than women, in US-born than Mexican born,
and in those with less education (12 years). These effects increase with
aging and length of follow-up (not shown). Conclusions: Comparisons of
dementia risk across ethnic groups are affected by differences in competing
risk of death. Cross national comparisons are vulnerable to this bias
because early mortality varies dramatically between developed and devel-
oping countries.
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Background: Previous findings of the impact of smoking on the risk of
dementia and Alzheimer’s disease (AD) have been controversial. Nowadays,
tobacco is recognized as a predisposing factor to dementia and AD. It has also
been suggested that the effect of smoking may differ between APOE 4
carriers and non-carriers. Our study evaluates the effect of smoking on the risk
of dementia and AD in a large, population based prospective study. Methods:
Cardiovascular Risk Factors, Aging and Dementia (CAIDE) study in eastern
Finland includes 2000 participants who were randomly selected from four
separate population-based samples originally studied in midlife (1972, 1977,
1982 or 1988). After an average follow-up time of 21 years altogether1449
(73%) individuals aged 65-79 years took part in a re-examination in 1998. 61
persons were diagnosed with dementia and 48 had AD. In addition, dementia
diagnoses of the non-participants were derived from the patient records of local
hospitals and health centres. Consequently, the total number of persons with
dementia and AD increased to 117 and 76, respectively. Smoking was assessed
in midlife with a detailed questionnaire, and the subjects were classified as
current, former or non-smokers. Also pack-years (the average number of
cigarettes daily smoked divided by 20 and multiplied by the number of years
of smoking) were determined. Results: Smoking in midlife increased the risk
of dementia (OR 4.93, 95% CI 1.51-16.11) and AD (OR 6.56, 95% CI
1.80-23.94) among APOE 4 carriers after adjustment for sociodemographic
risk factors, vascular risk factors and events and lung diseases. The risk was
more pronounced among those APOE 4 carriers who smoked and also
frequently drank alcohol (for dementia OR 17.24, 95% CI 1.95-152.37 and for
AD OR 11.05, 95% CI 1.08-113.30). There was no association found between
smoking and dementia or AD among APOE 4 non-carriers. Pack-years were
not related to dementia. Conclusions: In this study smoking was found to
increase the risk of dementia and AD only among APOE 4 carriers. These
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